[Bacteremia by Actynomices oris]

J M Martín Guerra; M Martín Asenjo; C Iglesias Pérez; C J Dueñas Gutiérrez

[Bacteremia by Actynomices oris]

Rev Esp Quimioter. 2019 Aug;32(4):393-394. Epub 2019 Jul 15.

[Article in Spanish]

Authors

J M Martín Guerra¹, M Martín Asenjo, C Iglesias Pérez, C J Dueñas Gutiérrez

Affiliation

¹ Javier Miguel Martín Guerra, Hospital Clínico Universitario de Valladolid. Avda. Ramón y Cajal, 1. 47005. Valladolid, Spain. javi6vega@hotmail.com.

PMID: 31310086
PMCID: PMC6719641

No abstract available

©The Author 2019. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Publication types

Case Reports
Letter

MeSH terms

Actinomyces* / drug effects
Actinomyces* / isolation & purification
Actinomycosis / drug therapy
Actinomycosis / microbiology*
Adult
Amoxicillin-Potassium Clavulanate Combination / therapeutic use
Anti-Bacterial Agents / therapeutic use
Bacteremia / drug therapy
Bacteremia / microbiology*
Ceftazidime / therapeutic use
Cerebellar Neoplasms / drug therapy
Daptomycin / therapeutic use
Humans
Male
Medulloblastoma / drug therapy

Substances

Anti-Bacterial Agents
Amoxicillin-Potassium Clavulanate Combination
Ceftazidime
Daptomycin

Supplementary concepts

Actinomyces oralis